No Data
No Data
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
William Blair Maintains NewAmsterdam Pharma(NAMS.US) With Buy Rating
William Blair Keeps Their Buy Rating on NewAmsterdam Pharma Company (NAMS)
NewAmsterdam Pharma to Present at the 24th Annual Needham Virtual Healthcare Conference
Piper Sandler Maintains NewAmsterdam Pharma(NAMS.US) With Buy Rating, Maintains Target Price $37
HH1000 : but but this is lunr
Growth Investor27 HH1000 : $Esperion Therapeutics (ESPR.US)$ To the Moon. It has been sold hort & forced lower before an offer comes
HH1000 Growth Investor27 : i bought some calls for earnings a little while back. will see how that goes
72792912 : I no longer believe any positive rumors about this company
Rich2023 : Every day, some baseless rumors are spread.
View more comments...